Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 24033267)

1.

The plant extract of Pao pereira potentiates carboplatin effects against ovarian cancer.

Yu J, Chen Q.

Pharm Biol. 2014 Jan;52(1):36-43. doi: 10.3109/13880209.2013.808232. Epub 2013 Sep 13.

PMID:
24033267
2.

beta-carboline alkaloid-enriched extract from the amazonian rain forest tree pao pereira suppresses prostate cancer cells.

Bemis DL, Capodice JL, Desai M, Katz AE, Buttyan R.

J Soc Integr Oncol. 2009 Spring;7(2):59-65.

PMID:
19476740
3.

Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira.

Yu J, Drisko J, Chen Q.

Oncol Rep. 2013 Jul;30(1):149-56. doi: 10.3892/or.2013.2461. Epub 2013 May 14.

PMID:
23674070
4.

Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer.

Yu J, Ma Y, Drisko J, Chen Q.

Curr Ther Res Clin Exp. 2013 Dec;75:8-14. doi: 10.1016/j.curtheres.2013.04.001.

5.

A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways.

Jia L, Jin H, Zhou J, Chen L, Lu Y, Ming Y, Yu Y.

BMC Complement Altern Med. 2013 Feb 15;13:33. doi: 10.1186/1472-6882-13-33.

6.

Role of triptolide as an adjunct chemotherapy for ovarian cancer.

Westfall SD, Nilsson EE, Skinner MK.

Chemotherapy. 2008;54(1):67-76. Epub 2007 Dec 10.

PMID:
18073474
7.

Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.

Scalici JM, Harrer C, Allen A, Jazaeri A, Atkins KA, McLachlan KR, Slack-Davis JK.

Gynecol Oncol. 2014 Feb;132(2):455-61. doi: 10.1016/j.ygyno.2013.12.031. Epub 2013 Dec 28.

8.

The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.

Witham J, Valenti MR, De-Haven-Brandon AK, Vidot S, Eccles SA, Kaye SB, Richardson A.

Clin Cancer Res. 2007 Dec 1;13(23):7191-8.

9.

The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells.

Whitworth JM, Londoño-Joshi AI, Sellers JC, Oliver PJ, Muccio DD, Atigadda VR, Straughn JM Jr, Buchsbaum DJ.

Gynecol Oncol. 2012 Apr;125(1):226-30. doi: 10.1016/j.ygyno.2011.12.425. Epub 2011 Dec 9.

10.

Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model.

Wang L, Chen H, Pourgholami MH, Beretov J, Hao J, Chao H, Perkins AC, Kearsley JH, Li Y.

PLoS One. 2011;6(9):e24405. doi: 10.1371/journal.pone.0024405. Epub 2011 Sep 9.

11.

Growth inhibition and apoptosis of Ehrlich ascites carcinoma cells by the methanol extract of Eucalyptus camaldulensis.

Islam F, Khatun H, Khatun M, Ali SM, Khanam JA.

Pharm Biol. 2014 Mar;52(3):281-90. doi: 10.3109/13880209.2013.834365. Epub 2013 Oct 9.

PMID:
24102623
12.

Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.

Yang YI, Kim JH, Lee KT, Choi JH.

Gynecol Oncol. 2011 Dec;123(3):588-96. doi: 10.1016/j.ygyno.2011.08.031. Epub 2011 Sep 25.

PMID:
21945308
13.

Inhibition of human ovarian cancer cell lines by devil's club Oplopanax horridus.

Tai J, Cheung S, Chan E, Hasman D.

J Ethnopharmacol. 2010 Feb 3;127(2):478-85. doi: 10.1016/j.jep.2009.10.010. Epub 2009 Oct 14.

PMID:
19835944
14.

Mirabijalone E: a novel rotenoid from Mirabilis himalaica inhibited A549 cell growth in vitro and in vivo.

Linghu L, Fan H, Hu Y, Zou Y, Yang P, Lan X, Liao Z, Chen M.

J Ethnopharmacol. 2014 Aug 8;155(1):326-33. doi: 10.1016/j.jep.2014.05.034. Epub 2014 May 29.

PMID:
24882730
15.

Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.

Rivard C, Geller M, Schnettler E, Saluja M, Vogel RI, Saluja A, Ramakrishnan S.

Gynecol Oncol. 2014 Nov;135(2):318-24. doi: 10.1016/j.ygyno.2014.08.031. Epub 2014 Aug 27.

PMID:
25172764
16.

Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model.

Bevis KS, McNally LR, Sellers JC, Della Manna D, Londoño Joshi A, Amm H, Straughn JM Jr, Buchsbaum DJ.

Gynecol Oncol. 2011 Apr;121(1):193-9. doi: 10.1016/j.ygyno.2010.11.046. Epub 2011 Jan 5.

PMID:
21211830
18.

Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.

Arend RC, Londoño-Joshi AI, Samant RS, Li Y, Conner M, Hidalgo B, Alvarez RD, Landen CN, Straughn JM, Buchsbaum DJ.

Gynecol Oncol. 2014 Jul;134(1):112-20. doi: 10.1016/j.ygyno.2014.04.005. Epub 2014 Apr 13.

PMID:
24736023
19.

Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis.

Peng B, Chang Q, Wang L, Hu Q, Wang Y, Tang J, Liu X.

Gynecol Oncol. 2008 Jan;108(1):173-81. Epub 2007 Oct 23.

PMID:
17959232
20.

Bioactivity-guided isolation of cytotoxic constituents from three medicinal plants.

Hullatti K, Pathade N, Mandavkar Y, Godavarthi A, Biradi M.

Pharm Biol. 2013 May;51(5):601-6. doi: 10.3109/13880209.2012.753919. Epub 2013 Jan 31.

PMID:
23363069
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk